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Background:
Medical error is a source of significant morbidity and mortality, and is often related to the prescription of medication(s) (). Prescription errors are related to inadequate knowledge or mistakes when dealing with relatively unfamiliar information whilst under pressure(, ). Lack of relevant knowledge is a special concern amongst newly qualified doctors(, ). These errors can lead to serious adverse outcomes for patients. They are also a source of inefficiency in healthcare systems().
Asthma and chronic obstructive airways disease (COPD) are common respiratory conditions which require long-term therapy in the form of inhaled medication. The global burden of these conditions is significant and increasing, with the WHO estimating they affect over 500 million people(). Providing inhaled medication for airways disease is a major financial burden for healthcare systems.
It is common for individuals on inhaled treatment to be admitted to hospital, and on admission junior doctors prescribe these usual medications(, ). Medications which are available in different preparations, for example modified or slow release are more likely to generate prescription errors(). These factors are important for inhaled medication, as many are available in a number of varying strengths and combinations in different devices.  Any errors made in the prescription of inhalers are potentially more costly than for oral formulations as each erroneously prescribed device usually represents one month’s supply and cannot be reused once opened.
Despite the frequency of prescription, the high risk of errors, and the significant resultant cost, we are not aware of any studies that have specifically investigated the frequency of errors in prescription of inhaled medications. 
Aim of the Study:
Our aim was to quantify the type, frequency and cost of prescription errors for inhaled medication in clinical practice, and to determine if a simple educational intervention can improve the knowledge of junior doctors for these medications.
Ethical Approval: This study met criteria for service evaluation and in the United Kingdom ethical approval is not required for this.
Methods:
This prospective study was conducted at a university teaching hospital in the United Kingdom with approximately 700 beds. Data werewas collected in two ways:
1. Inhaler Prescription Errors
We collected data on prescription of inhalers for all admissions from an electronic prescribing system (JAC, Basildon, UK). The initial data collection period was each weekend (from 5pm Friday to 8am Monday) from 17th May to 15th July 2013.We recorded instances where an initial prescription was corrected by a pharmacist, who had obtained a full medication history. The incorrect prescription was classified as being for the wrong device, strength, or drug, or a combination of these problems. Examples of these errors are shown in Table 1.
The cost of the incorrectly prescribed inhaler was drawn from the hospital’s internal formulary costing: 
2. Knowledge Assessment 
We ascertained the knowledge of inhaled therapy amongst junior staff through a quiz directly delivered at teaching sessions for Foundation level (year 1 and 2) doctors. This quiz comprised of a slideshow with short questions developed by the authors and delivered by a respiratory clinician.The questions were simple such as identifying a common device (e.g. Accuhaler®), showing a picture of a device and asking to name a possible medication that could be delivered with it (e.g. Turbohaler®).
Educational intervention
In August 2013 with the new intake of junior doctors, we introduced inhaler flashcards onto medical wards and admission areas, and publicised their availability and locations. Awareness was raised through teaching sessions for junior doctors and lunchtime speciality meetings, where these were shown. The packs of laminated cards had pictures of inhaler devices on one side with instructions on their use on the reverse, devised by specialist nurses, respiratory doctors, and pharmacists. These are shown in the supplementary materials.
Both the inhaler prescription data collection and knowledge assessment were repeated four weeks after the introduction of inhaler flash cards. The prescription data werewas collected during the weekends between the 30th August and 20th October 2013, and the knowledge assessment quiz was repeated at teaching sessions in October 2013.
After completion of our study, we circulated an electronic questionnaire to staff members, including senior doctors and nurses of the hospital for feedback on the flash cards.
Analyses and Statistics:
The percentage error was calculated by dividing the number of prescriptions containing errors by the total number of prescriptions. The cost of per error was calculated by dividing the total cost of incorrect prescriptions by the total number of incorrect prescriptions. This was done separately for the two data collection periods, and overall. 
The percentage error ratefrequency and type wereof errors pre- and post- intervention was calculated compared using the chi square test. The frequency of error by inhaler device type used a combined set of pre- and post-intervention data. The Mann –Whitney Test was applied to the doctors’ quiz responses, and the t test was used to calculate the cost of for prescription errors. All analysis was undertaken in SPSS v21 (IBM)
Results:
Prescription errors:
A total of 504 inhalers were prescribed during the weekends studied and for 489 prescriptions (97%) an independent drug history was subsequently available. Prescription error was common throughout the study (14% of cases overall), with types of errors shown in figure 1.
Inhaler type was significantly associated with error rate by chi-square (p=6.8 x 10-8): Higher error rates were seen with prescriptions for Evohaler® and Accuhaler® (5323% of these 195 prescriptions for which full data was available contained an error, all involved Seretide®) than other devices (errors in 20 of 7.2% 219error rate prescriptions for which full data was available). 
The educational intervention was not associated with a significantly reduced error rate (14% (n=34/243) vs 13% (n=27/207), chi square p=0.79). The mean cost of prescribing errors was £47 per error before the intervention and £44 per error afterward (t test p=0.36, 95% CI for difference -3.6 to 10).
Knowledge Assessment:
Overall 30 doctors participated in the questionnaire before the introduction of inhaler cards, and 21 after. Median scores were 4/26 before the intervention and 5/26 afterwards (Mann-Whitney test p=0.17). 
Online Electronic Questionnaire
This drew 64 responses, with 66% of respondents being aware of the cards and 54% having either read or used them. Of these 76% found these either useful or extremely useful and suggested the need for staff training and teaching.

Discussion:
This study shows, for the first time, that errors in the prescription of common inhaled medication are frequent in secondary care and usually of a compound nature. They are also potentially costly, being the equivalent of adding an extra £7 to the cost of every inhaler prescribed. Error rates were highest for medications such as Seretide® (Fluticasone/Salmeterol) that can be prescribed in multiple doses and devices.
We studied weekends as junior doctors have greater time pressure, more distractions, and less supervision. Also pharmacy provision is lower. This means that prescription errors may bemore likely to occur, and translated into wrong drug being delivered and potentially administered.However, a study during the working week and on weekends simultaneously would have enabled us to confirm or refute this assumption.
The intervention of inhaler flash cards was chosen for its potential ease of implementation and the simple, clear design. These were concise with only necessary and relevant information to enable medical professionals to refer to them during their busy schedule. This simple intervention of disseminating inhaler flashcards was not associated with a change in junior doctors’ knowledge, nor in prescribing error frequency in our small, single centre study. 
We acknowledge the limitations of reporting “before and after” data recorded alongside a clinical intervention rather than a standalone research project. A key issue was the rotation of junior doctors, meaning overlapping but not identical sets of doctors undertook the two sets of assessment, and not all of those who completed the second assessment were aware of the flashcards. Our findings are therefore representative of a “real world” effect rather than a clear measure of the efficacy of the intervention.
This study highlights a gap in the knowledge of junior doctors, and current educational curriculum of medical students. The feedback received from the electronic questionnaire was positive, with all the respondents suggesting to continue using these cards on the wards and requesting more education and training in this area. The need for further studies has been highlighted in earlier studies looking at medication errors (, ). Harding et al tested junior doctors’ knowledge formally in their study, in a more comprehensive manner using extended matching choice questions (EMQs) and written unobserved structured clinical examination scenarios (WUSCE). They found a large proportion (range 51 -75% and 27-70% for EMQs and WUSCE) junior doctors failed in these ().  There is a suggestion for emphasis on this subject at undergraduate level and also for further teaching and training of the newly qualified medical professionals.We hope the findings in this report will inform the design of future prospective multicentre trials of educational interventions.
Conclusion:
Errors in the prescription of inhaled medications in hospital are very common and potentially costly for healthcare providers. A simple educational intervention of teaching sessions and flashcards did not reduce error rates.
Given the potential financial savings if errors are avoided, more complex interventions may well prove cost effective. 
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